助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   portal 在 消化系统疾病 分类中 的翻译结果: 查询用时:0.012秒
图标索引 在分类学科中查询
所有学科
消化系统疾病
外科学
特种医学
互联网技术
计算机软件及计算机应用
图书情报与数字图书馆
行政学及国家行政管理
信息经济与邮政经济
电信技术
更多类别查询

图标索引 历史查询
 

portal     
相关语句
  门静脉
    Role of Cyclooxygenase-2 in the Development of Portal Hypertension in Experimental Cirrhosis
    环氧合酶-2在实验性肝硬化门静脉高压形成中的作用
短句来源
    Clinical Observation on the Splenic Transfer Factors in the Treatment of Portal Hypertension: Analysis of Nine Cases
    脾脏转移因子治疗门静脉高压症的临床观察(附9例分析)
短句来源
    EVALUATION OF PORTAL CIRCULATION WITH 99mTc-MIBI IMAGING
    ~(99m)Tc-MIBI显象无创伤性诊断门静脉分流
短句来源
    COLOR DOPPLER SONOGRAPHY FOR STUDY OF PORTAL HEMODYNAMICS IN PATIENTS WITH LIVER CIRRHOSIS
    彩色多普勒超声对肝硬化门静脉血液动力学的研究
短句来源
    Measurements of Portal Venous Pressure in 120 Normal People
    120例正常人体门静脉压力测量
短句来源
更多       
  门脉
    The Study on the Regulatory Mechanism of ET-1、NO、PGL_2 and C-Type Natriuretic Peptide on Hyperdynamic Circulation in Hepatic Cirrhosis and Portal Hypertension
    ET-1、NO、PGL_2、C型利钠肽对肝硬化门脉高压高动力循环调控机制的研究
短句来源
    Effects of ET-1 on Portal Hypertension in Hepatic Cirrhosis and the Mechanism of CNP、Radix Salviae Miltiorrhizae on ET-1-Mediated Contraction of HSCs
    ET—1对肝硬化门脉高压的作用及CNP、丹参对ET—1介导肝星状细胞收缩的调控机制
短句来源
    Prognosis of Portal Cirrhosis (Long Term Follow-up of 245 cases)
    245例门脉性肝硬化的预后(长期随访观察)
短句来源
    An Experimental Study of the Relationship between Hepatic Fibrosis and Portal Hypertension
    肝纤维化与门脉高压关系的实验研究
短句来源
    Relationship between splanchnic plasma thromboxane A_2/prostacyclin levels and portal hemodynamics in cirrhotic dogs
    胆管结扎肝硬化犬血浆TXA_2/PGI_2变化及其与门脉血液动力学的关系
短句来源
更多       
  
    The Study on the Regulatory Mechanism of ET-1、NO、PGL_2 and C-Type Natriuretic Peptide on Hyperdynamic Circulation in Hepatic Cirrhosis and Portal Hypertension
    ET-1、NO、PGL_2、C型利钠肽对肝硬化脉高压高动力循环调控机制的研究
短句来源
    Effects of ET-1 on Portal Hypertension in Hepatic Cirrhosis and the Mechanism of CNP、Radix Salviae Miltiorrhizae on ET-1-Mediated Contraction of HSCs
    ET—1对肝硬化脉高压的作用及CNP、丹参对ET—1介导肝星状细胞收缩的调控机制
短句来源
    Prognosis of Portal Cirrhosis (Long Term Follow-up of 245 cases)
    245例脉性肝硬化的预后(长期随访观察)
短句来源
    An Experimental Study of the Relationship between Hepatic Fibrosis and Portal Hypertension
    肝纤维化与脉高压关系的实验研究
短句来源
    Relationship between splanchnic plasma thromboxane A_2/prostacyclin levels and portal hemodynamics in cirrhotic dogs
    胆管结扎肝硬化犬血浆TXA_2/PGI_2变化及其与脉血液动力学的关系
短句来源
更多       
  肝门
    It is called IPH in Japan, it's counterpart is called non-cirrhotic portal fibrosis(NCPF) in India and hepatoportal sclerosis(HPS)in America.
    因其肝功能较好,受消化道出血影响不大,预后多良好。 在日本称为IPH,在印度称为非硬化性门脉纤维化(non-cirrhotic portal fibrosis,NCPF),在美国称为肝门脉硬化(hepatoportalsclerosis,HPS)。
短句来源
    The diameters and average velocities of portal and splenic veins were measured at before and after therapy 1, 2, 3,4 weeks respectively.
    分别于治疗前、治疗后1周、2周、3周、4周测量肝门静脉、脾静脉的内径及平均血流速度,计算血流量。
短句来源
    Results were considered statistically significant at P<0.05.Results: 1. Enalapril reduced the portal venous average diameter by 5.3% (P>0.05) at 1 week and by 13.9%、15.3%、15.3% (P<0.05) at 2,3,4 weeks, and there were no significant difference among 2,3,4 weeks(P>0.05).
    结果:1.治疗组治疗后1、2、3、4周肝门静脉内径与治疗前比较分别下降5.3%(P>0.05)、13.9%、15.3%、15.3%(p<0.05),2、3、4周平均内径差别无统计学意义(P>0.05);
短句来源
    The biliary obstruction was caused by hepatoma 21 cases: liver portal lymph node metastasis with stomach cancer 8 cases, biliary carcinoma 6 and pancreatic cancer 6 cases .
    胃癌肝门淋巴结转移8例、肝癌21例、胆管癌6例、胰头癌6例。
短句来源
    Methods:108 SD rats were randomly divided into three equal groups: sham operation group(SO), SAP group, and SAP group treated with dexamethasone(DEX). The SAP model was brought about by injecting 0.1 mg/100 g of 5% sodium taurocholate into the pancreatic duct after the bile duct at the hepatic portal had been clamped.
    方法 :10 8只SD大鼠随机分为假手术组 (SO组 )、SAP组 (阻断肝门部胆管 ,向胰管逆行注入 5 %牛磺胆酸钠 0 .0 0 1mL·g 1 )及SAP地塞米松处理组 (DEX组 ,即给SAP大鼠腹腔注射DEX 0 .0 1mL·g 1 ) ,每组 3 6只。
短句来源
更多       

 

查询“portal”译词为其他词的双语例句

     

    查询“portal”译词为用户自定义的双语例句

        我想查看译文中含有:的双语例句
    例句
    为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
      portal
    We recognized and honoured the important contributions of these Chinese pioneers in portal hypertension, recurrent pyogenic cholangitis, hepatocellular carcinoma and liver transplantation.
          
    Splenic autotransplantation and oesophageal transection anastomosis in patients with portal hypertension (26 years clinical obse
          
    The surgical treatment methods for cirrhosis patients complicated with portal hypertension are complicated.
          
    In this study, we evaluated the effectiveness of a new treatment strategy: splenic auto-transplantation and oesophageal transection anastomosis on 274 patients from three aspects: clinical observation, splenic immunology and portal dynamics.
          
    From 1979 to 2005, 274 cirrhosis patients with portal hypertension who underwent the new treatment strategy were followed up to observe different clinical indexes, which were then compared with those of the traditional surgery treatment.
          
    更多          


    The prognosis of portal cirrhosis of the liver is closely related to clinical features and many other factors. In this paper, we analyzed the long-term follow-up observation on 245 cases with portal cirrhosis of the liver hospitalized in Tianjin Medical College Hospital from 1947 to 1959, in order to find out the relationship between the prognosis and certain clinical features.In this series, 54.28 months was the average clinical course from beginning of the 1st symptom to the time at which the patient...

    The prognosis of portal cirrhosis of the liver is closely related to clinical features and many other factors. In this paper, we analyzed the long-term follow-up observation on 245 cases with portal cirrhosis of the liver hospitalized in Tianjin Medical College Hospital from 1947 to 1959, in order to find out the relationship between the prognosis and certain clinical features.In this series, 54.28 months was the average clinical course from beginning of the 1st symptom to the time at which the patient died or at which the last followup was performed. The mortality rate was highest, around 50%, within the 1st year after appearance of the 1st symptom, afterwards the mortality rate was markedly decreased and become stationary to some extent.Of 190 cases with ascites, 31 months was the average duration from appearance of ascites to the time at which the patient died or at which the last follow-up was performed. The longest survival term after appearance of ascites was 31 years. The highest mortality rate occurred in the 1st year after the appearance of ascites and was more than fifty percents. Afterwards, the mortality rate was markedly decreased.In 130 cases with massive gastrointestinal hemorrhage, 34.39 months was the average duration from the onset of hemorrhage to the time at which the patient died or at which the last follow-up was performed. The highest mortality rate occurred within the 1st eight weeks after the onset of hemorrhage and was more than fifty percent. Afterwards the mortality rate was markedly decreased.In 81 cases with jaundice, 30.42 months was the average duration from the appearance of jaundice to the time at which the patient died or at which the last follow-up was performed. Approximatly two third of total number of patients died within the 1st 6 months. Afterwards the mortality rate was decreased markedly.In 111 cases of hepatic coma, 18.7 months was the average duration from appearing of hepatic coma to the time at which the patient died or at which the last follow-up was performed. The highest mortality rate occurred within the 1st 3 weeks after the appearance of hepatic coma, and was 82 percents. Afterwards the mortality rate was markedly decreased.Of the 235 cases died, account for 91% of the total number of patients of portal cirrhosis of liver hospitalized.The patients were still living up to the last follow-up in May 1980. Their survival duration were 22-31 years (average 25.6 years). All of their ascites and jaundice subsided, splenomegaly and liver function tests showed improvement. There were two factors responsible for the long survival time: (1) the prognosis was better in female patients than in male; (2) the cases with marked splenomegaly survived longer than those without marked splenomegaly. Our managements were dietary care, little drugs taken and not drinking alcohol. One patient had been operated upon with splenectomy.

    1.本文对245例门脉性肝硬化患者进行随访,观察期限最长者为31年。 2.自第一症状出现至死亡或随访时的平均病程为54.28月。第一症状出现后1年内死亡率最高,约近半数。以后则死亡率显著下降,且呈比较稳定的状态。 3.女性患者的预后较男性为佳,以脾肿大为开始的病例预后较好。 4.190例有腹水者,自腹水出现至死亡或随访的平均期限为31月。出现腹水后生存最久的病例为31年。腹水出现1年内的死亡率最高,已超过一半,此后则显著降低。 5.消化道大出血者130例,自第一次出血至死亡或随访之平均期限为34.39月。第一次出血8周内死亡率最高,超过一半,以后则显著下降。 6.81例有黄疸者,自黄疸出现至死亡或随访之平均期限为30.42月。黄疸出现半年内,约有2/3病例已经死亡,以后则死亡率大减。 7.肝昏迷患者111例,自昏迷出现至死亡之平均期限为18.7月。肝昏迷出现之3周内死亡率最高(82%)。此后则显著降低。 8.已经死亡之235例,其由肝病致死者为91%。

    From the year 1962 to 1982, 22 patients with chylous ascites were admitted to our hospital. In 11 of them, it was found to be caused by hepatic cirrhosis with portal hypertension. The incidence of chylous ascites caused by hepatic cirrhosis in our series was much higher than that reportad in western countries. The clinical data of 11 such cases were analysed in this paper.All the 11 cases responded unfavorably to prolonged diuretic and supportive treatments. Auto-ascitic fluid concentration-reinfusion...

    From the year 1962 to 1982, 22 patients with chylous ascites were admitted to our hospital. In 11 of them, it was found to be caused by hepatic cirrhosis with portal hypertension. The incidence of chylous ascites caused by hepatic cirrhosis in our series was much higher than that reportad in western countries. The clinical data of 11 such cases were analysed in this paper.All the 11 cases responded unfavorably to prolonged diuretic and supportive treatments. Auto-ascitic fluid concentration-reinfusion was later performed in 8 patients with promising results. Aftar subsidence of the chylous ascites, 3 of them underwent meso-caval shunt, one was further treated by peritoneovenous shunting with a LeVeen tube, and another one by a thoracicduct-internal jugular anastomosis.The incidence, pathogenesis and treatment of chylous ascites due to hepatic cirrhosis were briefly discussed.

    近20年来本院共收治乳糜腹水22例,其中11例的病因经确诊为肝硬化,占同时期乳糜腹水病例的半数。本系列中肝硬化乳糜腹水的发病率显著高于国外资料。11例中8例采用腹水浓缩静脉回输治疗,此8例中5例分别进行了肠系膜上静脉-下腔静脉分流术(3例),Leveen管分流术(1例)及胸导管-颈静脉分流术(1例)。本文就肝硬化乳糜腹水的发病率、发病机理及治疗,结合文献进行讨论。

    The author presents here 48 cases of portal hypertension treated with splenorenal shunt from 1974 to 1983. All of them were of the intrahepatic type. 20 cases underwent elective, 4 emergency and 24 prophylactic shunts. The average postshunt portal pressure decrement was 105 mmH2O. There were 4 postoperative deaths ( mortality 8.3% with 2 deaths in emergency, and none in the prophylactic shunt group). Over all follow-up rate was 95.5% (42 cases), and periods from 8 months to 9.6 years. 6 cases died...

    The author presents here 48 cases of portal hypertension treated with splenorenal shunt from 1974 to 1983. All of them were of the intrahepatic type. 20 cases underwent elective, 4 emergency and 24 prophylactic shunts. The average postshunt portal pressure decrement was 105 mmH2O. There were 4 postoperative deaths ( mortality 8.3% with 2 deaths in emergency, and none in the prophylactic shunt group). Over all follow-up rate was 95.5% (42 cases), and periods from 8 months to 9.6 years. 6 cases died within 1- 6.8 years postoperatively. The absolute survival rates in 1, 3 and 5 years after operation were 93.2%, 78.5% and 72.7% respectively. There were 2 cases of rebleeding(4.8%) and 6 of encephalopathy (14.3%). Most of the ence-phalopathy cases responded well to protein restriction and intestinal antibiosis. The central splenorenal anastomosis is performed via the inferior margin of the pancreas by dissecting out the central segment of the splenic vein, which is then anastomosed to the left renal vein. The anastomosis thus made is near to the portal vein and the inferior vena cava. The operation is easy to perform giving a low incidence of re-bleeding and encephalopathy.

    1974~1983年,我院采用中央型脾肾静脉分流术治疗肝内型门脉高压症48例,其中急症手术4例,择期手术20例,预防性分流术24例。术后近期死亡4例(有2例作急症分流),随访42例,最长9年8个月,平均为4年。远期死亡率14.3%,再出血率4.8%;脑病发生率14.3%;康复率88.9%;绝对生存率1、3及5年分别为93.2、78.5及72.7%。此术式系经胃结肠韧带切开的途径暴露胰腺体部,掀起胰体前下缘,游离胰体后脾静脉中央段,使之与肾静脉吻合,优点为操作简便、出血少、吻合口较大血流通畅、降压效果好,平均降压105mmH_2O,再出血率较低,分流量因受肾静脉容量限制,故门脉血流对肝灌注影响不太大,脑病发生率未高出周围型脾肾静脉分流术。

     
    << 更多相关文摘    
    图标索引 相关查询

     


     
    CNKI小工具
    在英文学术搜索中查有关portal的内容
    在知识搜索中查有关portal的内容
    在数字搜索中查有关portal的内容
    在概念知识元中查有关portal的内容
    在学术趋势中查有关portal的内容
     
     

    CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
    版权图标  2008 CNKI-中国知网
    京ICP证040431号 互联网出版许可证 新出网证(京)字008号
    北京市公安局海淀分局 备案号:110 1081725
    版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社